Literature DB >> 27600051

Disruption of Membrane by Colistin Kills Uropathogenic Escherichia coli Persisters and Enhances Killing of Other Antibiotics.

Peng Cui1,2, Hongxia Niu3, Wanliang Shi2, Shuo Zhang2, Hao Zhang2, Joseph Margolick2, Wenhong Zhang4, Ying Zhang5,1.   

Abstract

Persisters are small populations of quiescent bacterial cells that survive exposure to bactericidal antibiotics and are responsible for many persistent infections and posttreatment relapses. However, little is known about how to effectively kill persister bacteria. In the work presented here, we found that colistin, a membrane-active antibiotic, was highly active against Escherichia coli persisters at high concentrations (25 or 50 μg/ml). At a clinically relevant lower concentration (10 μg/ml), colistin alone had no apparent effect on E. coli persisters. In combination with other drugs, this concentration of colistin enhanced the antipersister activity of gentamicin and ofloxacin but not that of ampicillin, nitrofurans, and sulfa drugs in vitro The colistin enhancement effect was most likely due to increased uptake of the other antibiotics, as demonstrated by increased accumulation of fluorescence-labeled gentamicin. Interestingly, colistin significantly enhanced the activity of ofloxacin and nitrofurantoin but not that of gentamicin or sulfa drugs in the murine model of urinary tract infection. Our findings suggest that targeting bacterial membranes is a valuable approach to eradicating persisters and should have implications for more effective treatment of persistent bacterial infections.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27600051      PMCID: PMC5075097          DOI: 10.1128/AAC.01481-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.

Authors:  Matthew G Blango; Matthew A Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

Review 2.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.

Authors:  Kalpana Gupta; Thomas M Hooton; Kurt G Naber; Björn Wullt; Richard Colgan; Loren G Miller; Gregory J Moran; Lindsay E Nicolle; Raul Raz; Anthony J Schaeffer; David E Soper
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079

Review 3.  Novel approaches to combat bacterial biofilms.

Authors:  Christophe Beloin; Stéphane Renard; Jean-Marc Ghigo; David Lebeaux
Journal:  Curr Opin Pharmacol       Date:  2014-09-23       Impact factor: 5.547

4.  Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli.

Authors:  Fernando Docobo-Pérez; Patrice Nordmann; Juan Domínguez-Herrera; Rafael López-Rojas; Younes Smani; Laurent Poirel; Jerónimo Pachón
Journal:  Int J Antimicrob Agents       Date:  2011-12-07       Impact factor: 5.283

Review 5.  Colistin, mechanisms and prevalence of resistance.

Authors:  Abed Zahedi Bialvaei; Hossein Samadi Kafil
Journal:  Curr Med Res Opin       Date:  2015-03-19       Impact factor: 2.580

6.  Lipid binding and membrane penetration of polymyxin B derivatives studied in a biomimetic vesicle system.

Authors:  Marina Katz; Haim Tsubery; Sofiya Kolusheva; Alex Shames; Mati Fridkin; Raz Jelinek
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

7.  A murine model of urinary tract infection.

Authors:  Chia-Suei Hung; Karen W Dodson; Scott J Hultgren
Journal:  Nat Protoc       Date:  2009-07-30       Impact factor: 13.491

8.  Silver enhances antibiotic activity against gram-negative bacteria.

Authors:  J Ruben Morones-Ramirez; Jonathan A Winkler; Catherine S Spina; James J Collins
Journal:  Sci Transl Med       Date:  2013-06-19       Impact factor: 17.956

9.  Inhibition of stationary phase respiration impairs persister formation in E. coli.

Authors:  Mehmet A Orman; Mark P Brynildsen
Journal:  Nat Commun       Date:  2015-08-06       Impact factor: 14.919

10.  Identification of Anti-Persister Activity against Uropathogenic Escherichia coli from a Clinical Drug Library.

Authors:  Hongxia Niu; Peng Cui; Wanliang Shi; Shuo Zhang; Jie Feng; Yong Wang; David Sullivan; Wenhong Zhang; Bingdong Zhu; Ying Zhang
Journal:  Antibiotics (Basel)       Date:  2015-05-12
View more
  14 in total

1.  Metabolites Potentiate Nitrofurans in Nongrowing Escherichia coli.

Authors:  Sandra J Aedo; Juechun Tang; Mark P Brynildsen
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

2.  Screen of Unfocused Libraries Identified Compounds with Direct or Synergistic Antibacterial Activity.

Authors:  Claudia Mugnaini; Filomena Sannio; Antonella Brizzi; Rosita Del Prete; Tiziana Simone; Teresa Ferraro; Filomena De Luca; Federico Corelli; Jean-Denis Docquier
Journal:  ACS Med Chem Lett       Date:  2020-03-06       Impact factor: 4.345

Review 3.  Causes of polymyxin treatment failure and new derivatives to fill the gap.

Authors:  Selena Chiu; Anna M Hancock; Bob W Schofner; Katherine J Sniezek; Nashaly Soto-Echevarria; Gabrielle Leon; Darshan M Sivaloganathan; Xuanqing Wan; Mark P Brynildsen
Journal:  J Antibiot (Tokyo)       Date:  2022-09-20       Impact factor: 3.424

4.  Generation of Persister Cells of Pseudomonas aeruginosa and Staphylococcus aureus by Chemical Treatment and Evaluation of Their Susceptibility to Membrane-Targeting Agents.

Authors:  Lucia Grassi; Mariagrazia Di Luca; Giuseppantonio Maisetta; Andrea C Rinaldi; Semih Esin; Andrej Trampuz; Giovanna Batoni
Journal:  Front Microbiol       Date:  2017-10-04       Impact factor: 5.640

5.  Antibacterial Activity of 1-[(2,4-Dichlorophenethyl)amino]-3-Phenoxypropan-2-ol against Antibiotic-Resistant Strains of Diverse Bacterial Pathogens, Biofilms and in Pre-clinical Infection Models.

Authors:  Valerie Defraine; Laure Verstraete; Françoise Van Bambeke; Ahalieyah Anantharajah; Eleanor M Townsend; Gordon Ramage; Romu Corbau; Arnaud Marchand; Patrick Chaltin; Maarten Fauvart; Jan Michiels
Journal:  Front Microbiol       Date:  2017-12-22       Impact factor: 5.640

6.  Novel Glycopolymer Eradicates Antibiotic- and CCCP-Induced Persister Cells in Pseudomonas aeruginosa.

Authors:  Vidya P Narayanaswamy; Laura L Keagy; Kathryn Duris; William Wiesmann; Allister J Loughran; Stacy M Townsend; Shenda Baker
Journal:  Front Microbiol       Date:  2018-08-03       Impact factor: 5.640

7.  Identification of essential oils with activity against stationary phase Staphylococcus aureus.

Authors:  Shuzhen Xiao; Peng Cui; Wanliang Shi; Ying Zhang
Journal:  BMC Complement Med Ther       Date:  2020-03-24

Review 8.  UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies.

Authors:  Maria E Terlizzi; Giorgio Gribaudo; Massimo E Maffei
Journal:  Front Microbiol       Date:  2017-08-15       Impact factor: 5.640

9.  Variable Persister Gene Interactions with (p)ppGpp for Persister Formation in Escherichia coli.

Authors:  Shuang Liu; Nan Wu; Shanshan Zhang; Youhua Yuan; Wenhong Zhang; Ying Zhang
Journal:  Front Microbiol       Date:  2017-09-20       Impact factor: 5.640

10.  Identification of Essential Oils with Strong Activity against Stationary Phase Borrelia burgdorferi.

Authors:  Jie Feng; Wanliang Shi; Judith Miklossy; Genevieve M Tauxe; Conor J McMeniman; Ying Zhang
Journal:  Antibiotics (Basel)       Date:  2018-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.